Trial intelligence / Profile preview

Brinjal Peel Extract for Arsenical Keratosis and Bowen's Disease

NCT03641079Phase 2Unknown

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Sep 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of brinjal peel extract in Arsenical keratosis, squamous cell carcinoma in situ (SCCIS), sponsored by Bangabandhu Sheikh Mujib Medical University. Status: unknown.

02

Drugs

brinjal peel extract
03

Conditions

Arsenical keratosissquamous cell carcinoma in situ (SCCIS)

Beyond the preview

Go deeper on NCT03641079.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03641079.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call